At Synaptrix, we are pioneering accessible technologies to empower individuals with paralysis to live more independently.
Our first device, Neuralis™, is a non-invasive, EEG based neural interface that allows paralyzed individuals to control the wheelchair they already use with their brain activity and eye movements. By interpreting signals from visual cortex, Neuralis™ enables intuitive and effortless wheelchair navigation. Neuralis™ is specially designed to meet the needs of paralyzed patients with conditions like ALS, spinal cord injury, MS, strokes, and other neurodegenerative conditions. It provides an affordable alternative to complex, expensive solutions that are often impractical for daily independence.
At Synaptrix, we are committed to improving the quality of life for individuals with physical limitations. Through our research, we seek to contribute to the advancement of assistive technologies for patients with neurological conditions, emphasizing the importance of regaining autonomy and control over their lives.
Company Details
- Employees
- 9
- Founded
- -
- Address
- New York, New York 10010, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://synaptrix-labs.com
- HQ
- New York, New York
Synaptrix Labs Questions
Synaptrix Labs's website is https://synaptrix-labs.com
Synaptrix Labs's LinkedIn profile is https://www.linkedin.com/company/synaptrix-labs
Synaptrix Labs has
9 employees.
View email and phone details for 9
employees at Synaptrix Labs.
Synaptrix Labs's industry is
Biotechnology Research
Synaptrix Labs's top competitors are
Generative Neuroscience™,
Underdog Labs,
Latte,
Lifestack By Demind Inc.,
Neuro Health Alliance,
Synaptrix | Novabloc,
Hadron Founders Club,
Grata Health,
Synchron,
Plethy.
Synaptrix Labs's categories are Biotechnology Research
Synaptrix Labs's founding year is 2023
